Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Apr 30, 2026
TickeronGET DAILY SIGNALS
Altria (MO): What to Watch in Q1 2026 Earnings

Altria (MO): What to Watch in Q1 2026 Earnings

Key Takeaways

  • Analysts expect Q1 2026 adjusted EPS of $1.24, a slight increase from $1.23 in the year-ago quarter.
  • Consensus revenue estimate stands at $4.56 billion, reflecting 0.9% year-over-year growth.
  • Altria has reaffirmed its full-year 2026 adjusted diluted EPS guidance of $5.56 to $5.72, implying 2.5% to 5.5% growth.
  • Investors will watch smoke-free product shipment growth, including NJOY e-vapor and on! oral nicotine pouches.
  • Cigarette shipment volumes likely declined year-over-year, offset by pricing actions.
  • Historical post-earnings stock reactions have been muted, with focus on guidance updates.

Why Altria's Q1 Earnings Matter

As MO navigates declining cigarette volumes due to shifting consumer preferences toward reduced-risk products, the first-quarter 2026 earnings report—due before the market open today, April 30, 2026—provides key insights into its pricing power, progress in smoke-free categories, and ability to withstand illicit trade pressures. In recent quarters, I've noted adjusted EPS growth holding up despite volume challenges, thanks to robust margins. For investors like us, this report is a test of Altria's execution on its vision to lead in smoke-free products, while it reaffirms its full-year outlook amid regulatory scrutiny and economic headwinds in the tobacco sector.

Earnings Expectations

Wall Street looks for Altria to deliver first-quarter 2026 adjusted EPS of $1.24, a modest uptick from $1.23 in Q1 2025. Consensus revenue net of excise taxes sits at $4.56 billion, up 0.9% from $4.52 billion a year ago. One thing that stands out is the expected pricing strength, which should partially offset an estimated 8-10% decline in Marlboro cigarette shipments.

Smoke-free net revenues are projected to see double-digit growth, fueled by the NJOY e-vapor brand and on! oral nicotine pouches. Altria has consistently beaten EPS estimates in recent quarters, though revenues have come in line or slightly below. I'm watching closely for reaffirmation of the full-year adjusted EPS guidance of $5.56-$5.72, which would signal confidence in cost savings and investments in smoke-free initiatives. I also checked this using Tickeron’s AI Screener to gauge how MO stacks up against industry peers on these metrics.

AI Screener

One tool I rely on for deeper market scans is Tickeron’s AI Screener. This AI-powered platform helps me filter stocks and ETFs using technical patterns, fundamentals, trends, volatility, and predictive signals. It scans thousands of assets with customizable criteria like industry, market cap, indicators, price patterns, and performance data—saving time on manual screening to spot trade ideas, breakouts, and opportunities. In my analysis of MO, it's been particularly useful for comparing smoke-free growth peers.

Market Reaction and Sentiment

Heading into earnings, sentiment around MO feels cautiously optimistic, with shares up about 5% over the past month alongside broader market gains. The stock has demonstrated resilience near $66. Risks on the table include steeper-than-expected volume drops or regulatory news on menthol cigarettes. Historically, post-earnings moves have averaged under 3%, with direction often set by guidance and smoke-free updates.

Forward Outlook and Factors to Monitor

After Q1 results, any tweaks to full-year guidance—especially toward the $5.56-$5.72 adjusted EPS range—will be critical. Altria's push into smoke-free products, targeting over $1 billion in annual revenues, hinges on metrics like NJOY's retail share and on! pouch shipments.

From what I see, broader factors like stronger enforcement against illicit vapor and cigarettes could lift reported volumes. Pricing in combustibles remains a tailwind, though input cost pressures on margins deserve attention. Key dates ahead include the annual shareholder meeting on May 14 and Q2 results in late July.

Regulatory hurdles, such as FDA moves on menthol or synthetic nicotine, remain a concern. Cost savings from the $500 million+ program should support innovation. In my view, steady smoke-free momentum and stable guidance could bolster MO's appeal as a defensive play in a market seeking yield.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MO

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


MO's RSI Oscillator reaches overbought territory

The RSI Indicator for MO moved into overbought territory on October 30, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 29 of 64 cases where MO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 45%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 36%.

MO broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on MO as a result. In 50 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.

The Moving Average Convergence Divergence (MACD) for MO just turned positive on October 29, 2026. Looking at past instances where MO's MACD turned positive, the stock continued to rise in 27 of 45 cases over the following month. The odds of a continued upward trend are 60%.

MO moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +6.91% 3-day Advance, the price is estimated to grow further. Considering data from situations where MO advanced for three days, in 220 of 387 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.

The Aroon Indicator entered an Uptrend today. In 163 of 283 cases where MO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 58%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock better than average.

The Tickeron SMR rating for this company is 8 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MO's P/B Ratio (-48.834) is very low in comparison to the industry average of (-7.484). P/E Ratio (16.427) is within average values for comparable stocks, (13.071). Projected Growth (PEG Ratio) (2.649) is also within normal values, averaging (3.595). Dividend Yield (0.057) settles around the average of (0.060) among similar stocks. MO's P/S Ratio (5.744) is slightly higher than the industry average of (2.780).

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 19 (best 1 - 100 worst), indicating outstanding price growth. MO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

Notable companies

The most notable companies in this group are Philip Morris International (NYSE:PM), Altria Group (NYSE:MO).

Industry description

The industry is engaged in the growth, preparation for sale, advertisement, and distribution of tobacco and tobacco-related products like cigarettes. In 2017, tobacco companies spent an estimated $9.36 billion marketing cigarettes and smokeless tobacco in the U.S. – an amount that translates to more than $25 million each day (according to a CDC report). Philip Morris International Inc., Altria Group Inc., and British American Tobacco plc are some major cigar makers. In recent times, vaping or the use of e-cigarette (does not burn tobacco) is gaining momentum – several established cigarette makers are trying to expand their footprint in this new market.

Market Cap

The average market capitalization across the Tobacco Industry is 59.02B. The market cap for tickers in the group ranges from 99 to 325.42B. PM holds the highest valuation in this group at 325.42B. The lowest valued company is AHII at 99.

High and low price notable news

The average weekly price growth across all stocks in the Tobacco Industry was -4%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was -20%. UVV experienced the highest price growth at 5%, while XXII experienced the biggest fall at -65%.

Volume

The average weekly volume growth across all stocks in the Tobacco Industry was -12%. For the same stocks of the Industry, the average monthly volume growth was 88% and the average quarterly volume growth was 57%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 42
P/E Growth Rating: 49
Price Growth Rating: 57
SMR Rating: 73
Profit Risk Rating: 68
Seasonality Score: 22 (-100 ... +100)
View a ticker or compare two or three
MO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a holding company which produces and markets tobacco products

Industry Tobacco

Industry
Tobacco
Address
6601 West Broad Street
Phone
+1 804 274-2200
Employees
5900
Web
https://www.altria.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.